How long can I take Alpelisib?

The duration of use of Alpelisib (Alpelisib) is usually determined by the doctor based on the patient's specific condition, disease characteristics, treatment response and other factors. Apelvis is commonly used to treat hormone receptor-positive (HR-positive), HER2-negative advanced breast cancer, especially those with PIK3CA gene mutations.

The length of treatment is individualized and depends on the patient's condition and response to treatment. Generally, apelvis is an oral medication that requires patients to continue taking it until disease progression or intolerable side effects occur. Treatment may take several months or longer.

During the use of Apelvis, doctors will conduct regular monitoring and evaluation to ensure the efficacy of the drug and the safety of the patient. This may include regular clinical examinations, imaging tests (eg CT scans, MRI scans, etc.), and laboratory tests. Your doctor may use the monitoring results to decide whether you need to adjust the dose, continue treatment, or take other appropriate measures.

Patients should pay close attention to their physical condition while taking Apelvis and promptly report any discomfort, side effects or other changes to their doctor. For specific decisions about the duration of treatment, patients need to work closely with their doctor to develop and implement a treatment plan.

Apelis has not yet been launched in China, so it is not included in medical insurance. Therefore, patients cannot purchase it domestically and need to purchase Apelis through overseas channels. In foreign countries, the original Apelvis drug is mainly used. There are European and Indian versions of the original drug on the market. The price of the European version of the original drug is as high as tens of thousands of yuan. Relatively speaking, the price of the Indian version of the original drug is around four to five thousand yuan. The price is still relatively cheap. Moreover, the ingredients and efficacy of the European and Indian original drugs are consistent.